AGIOS PHARMACEUTICALS, INC. Insider Trading for June 2018
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in AGIOS PHARMACEUTICALS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in AGIOS PHARMACEUTICALS, INC. for June 2018.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Option Exercise | M | 39.76 | 2,050 | 81,508 | 64,750 | |
Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Sell | S | 97.58 | 2,050 | 200,039 | 0 | 2.1 K to 0 (-100.00 %) |
Jun 26 2018 | AGIO | AGIOS PHARMACEUTIC ... | Hoerter Steven L. | Chief Commercial Of ... | Buy | M | 39.76 | 2,050 | 81,508 | 2,050 | 0 to 2.1 K |
Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | M | 50.73 | 9,000 | 456,570 | 0 | |
Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 94.30 | 839 | 79,118 | 2,200 | 3 K to 2.2 K (-27.61 %) |
Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 93.78 | 5,980 | 560,804 | 3,039 | 9 K to 3 K (-66.30 %) |
Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Sell | S | 92.62 | 2,181 | 202,004 | 9,019 | 11.2 K to 9 K (-19.47 %) |
Jun 18 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Buy | M | 50.73 | 9,000 | 456,570 | 11,200 | 2.2 K to 11.2 K (+409.09 %) |
Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Option Exercise | M | 35.16 | 2,000 | 70,320 | 95,000 | |
Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 93.37 | 200 | 18,674 | 881 | 1.1 K to 881 (-18.50 %) |
Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Sell | S | 92.84 | 1,800 | 167,112 | 1,081 | 2.9 K to 1.1 K (-62.48 %) |
Jun 14 2018 | AGIO | AGIOS PHARMACEUTIC ... | Bowden Christopher | Chief Medical Offic ... | Buy | M | 35.16 | 2,000 | 70,320 | 2,881 | 881 to 2.9 K (+227.01 %) |
Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Option Exercise | M | 9.05 | 3,000 | 27,150 | 19,154 | |
Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 94.28 | 939 | 88,529 | 57,196 | 58.1 K to 57.2 K (-1.62 %) |
Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 93.27 | 1,259 | 117,427 | 58,135 | 59.4 K to 58.1 K (-2.12 %) |
Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Sell | S | 92.45 | 802 | 74,145 | 59,394 | 60.2 K to 59.4 K (-1.33 %) |
Jun 07 2018 | AGIO | AGIOS PHARMACEUTIC ... | Biller Scott | Chief Scientific Of ... | Buy | M | 9.05 | 3,000 | 27,150 | 60,196 | 57.2 K to 60.2 K (+5.25 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 2.34 | 108 | 253 | 72,619 | |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.47 | 12,892 | 6,027 | 0 | |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 96.91 | 100 | 9,691 | 0 | 100 to 0 (-100.00 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 96.40 | 3,190 | 307,516 | 100 | 3.3 K to 100 (-96.96 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 95.11 | 8,200 | 779,902 | 3,290 | 11.5 K to 3.3 K (-71.37 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 94.37 | 1,510 | 142,499 | 11,490 | 13 K to 11.5 K (-11.62 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 2.34 | 108 | 253 | 13,000 | 12.9 K to 13 K (+0.84 %) |
Jun 05 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.47 | 12,892 | 6,027 | 12,892 | 0 to 12.9 K |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Scadden David | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | MARAGANORE JOHN | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Foster-Cheek Kaye I | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | CLARK IAN T | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 0.00 | 1,400 | 0 | 1,400 | |
Jun 04 2018 | AGIO | AGIOS PHARMACEUTIC ... | Clancy Paul J | Director | Option Exercise | A | 93.50 | 5,700 | 532,950 | 5,700 | |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.47 | 23,471 | 10,973 | 12,892 | |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 16,193 | 4,898 | 0 | |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Option Exercise | M | 0.30 | 5,962 | 1,804 | 0 | |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Sell | S | 90.07 | 45,626 | 4,109,534 | 0 | 45.6 K to 0 (-100.00 %) |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.47 | 23,471 | 10,973 | 45,626 | 22.2 K to 45.6 K (+105.94 %) |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 16,193 | 4,898 | 22,155 | 6 K to 22.2 K (+271.60 %) |
Jun 01 2018 | AGIO | AGIOS PHARMACEUTIC ... | Schenkein David P | Chief Executive Off ... | Buy | M | 0.30 | 5,962 | 1,804 | 5,962 | 0 to 6 K |